ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 763059 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 763059; 2) Community: the network communities that were significantly associated with the response to NSC 763059; 3) Molecule: the relationships between components within communities and NSC 763059; 4) MDR: the compounds that were significantly associated with the NSC 763059.

NSC Compound Enrichment Correlation
NSC 711113 3,3-bis[4-(4-aminoiphenoxy)phenyl]diamantane 0.00415749398947839 0.031161729
NSC 748873 Null 0.00415749398947839 0.42552663
NSC 755264 Null 0.00415749398947839 0.21500835
NSC 760016 (E)-3-(3,5-dimethoxyphenyl)-1-(4-(quinazolin-4-ylamino)phenyl)prop-2-en-1-one 0.00415749398947839 0.25725051
NSC 83321 Null 0.00415749398947839 0.13188873
NSC 107124 Camptothecin Derivative 0.00423163567577551 0.1205557
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.00423163567577551 0.39521542
NSC 137443 Kalafungin(USAN) 0.00423163567577551 0.096560906
NSC 236580 .beta.-Alanine, N-[N-[N-[N-[1-(D-2-hydroxy-4-methyl-1-oxopentyl)-L-prolyl]-L-isoleucyl]-N-methyl-L-valyl]-N-methyl-L-alanyl]-, .rho.-lactone 0.00423163567577551 0.26336687
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.00423163567577551 0.16112781
Total:116  Current:13    [First] [Prev] [Next] [Last]